MNK:癌症免疫治疗的新有前途的目标
Pei Shu1,2, Yanna Lei3, Ge Gao2
1Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University.
Current medicinal chemistry
|February 4, 2024
概括
线素激活蛋白激酶相互作用激酶 (MNKs) 是癌症免疫治疗的新目标. 了解MNK功能可以扩大更多癌症患者的治疗选择.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 癌症免疫疗法,特别是针对免疫检查点,已在晚期癌症中取得成功.
- 有限的反应率阻碍了当前免疫疗法的更广泛应用.
- 需要新的治疗目标来改善患者的治疗结果.
研究的目的:
- 检查小基因激活蛋白激酶-相互作用激酶 (MNKs) 的结构,功能和表达.
- 阐明MNKs在瘤进展和癌症生物学中的作用.
- 评估MNKs作为癌症免疫治疗的潜在新目标.
主要方法:
- 对癌症中MNKs现有研究的文献综述.
- 分析MNK结构,功能和表达模式.
- 检查MNK参与癌症的发展和进展.
主要成果:
- 在癌症生物学和治疗中,MNKs起着重要的作用.
- 有证据表明,MNK与癌症进展密切相关.
- 多核瘤代表了一个有前途的新治疗点.
结论:
- 对MNK的全面理解对于开发新的癌症治疗方法至关重要.
- 向MNK可能提供一种新的策略来增强癌症免疫疗法.
- 对MNK的进一步研究可以将免疫治疗的益处扩展到更多患者身上.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163